Caplacizumab Dosing Rational in aTTP Patients Supported by Mechanism Based PKPD Modelling

MIDD

Specific populations

Pharmacometrics

Hematology

PAGE 28 (2019) Abstr 8800.

Bergstrand M, Hansson E, Sargentini-Maier ML